I started by watching videos, and I chose 10,000 combat power.

Luo Fei didn't say anything and hung up the phone immediately.

Yamamoto Corporation? Japanese? Business negotiations? And they want me to go to Shanghai to negotiate? What a nerve!

He twitched the corner of his mouth slightly, but didn't think about it anymore.

He found Su Wanqing's number and was about to dial it.

My phone was interrupted again by the same number.

Luo Fei glanced at it for two seconds, then answered the call.

"Mr. Luo Fei," Yamamoto Ichiro's voice was even more urgent than before, "please don't hang up yet, we are truly sincere."

"I have no business to discuss with you Japanese."

Luo Fei replied calmly, and then hung up again.

Before he could do anything, his phone rang again.

It was another unfamiliar number, from Shanghai, so I answered it without hesitation.

"Feed?"

A woman's voice came from the other end of the phone, speaking fluent Mandarin, but with a distinct foreign accent.

"Hello Mr. Luo Fei, I apologize for bothering you. I am Emily, the head of the Locke family's representative office in China."

"Our family is very interested in you and would like to invite you to Shanghai to discuss some cooperation matters."

Luo Fei's eyes narrowed slightly.

The Locke family? That conglomerate in the US with a history spanning over a hundred years?

He paused for a second.

"Sorry, I'm not interested."

He hung up the phone without waiting for a response.

He hadn't put his phone down yet.

It rang again.

The third unfamiliar number.

Luo Fei frowned slightly as he looked at the numbers flashing on the screen, wondering why there were so many unfamiliar calls today. He answered anyway.

"Feed?"

"Hello Mr. Luo Fei, I am Hans Müller, the head of the German Bayer Pharmaceutical Group's branch in China."

"Our group very much hopes to meet with you to discuss some important collaborations. Please feel free to bring up any conditions you may have."

Luo Fei's brows furrowed even more.

He didn't say anything and hung up immediately.

The fourth call came in.

Luo Fei stared at the screen, remained silent for two seconds, feeling somewhat irritated, but still answered the call.

"Hello Mr. Luo Fei, I am from the Sanofi pharmaceutical company's representative office in China..."

"Mr. Luo Fei, I am from GlaxoSmithKline (GSK)..."

"Mr. Luo Fei, I am from Takeda Pharmaceutical Co., Ltd., Japan..."

The phone kept ringing.

Numbers of various cities in China.

They are all branches of large foreign conglomerates and pharmaceutical companies in China.

He stared at his phone screen, lost in thought.

So many companies and so many conglomerates came knocking on our door almost simultaneously.

He leaned against the headboard, fiddling with his phone, his mind racing.

They were probably after Bai Ruizhe's leukemia treatment drug.

According to the previous agreement, after the drug is launched on the market, the state will hold 90% of the shares, and he will personally hold 10%.

Those who knew about this before were probably limited to high-ranking officials and relevant department heads in China.

It now appears that the company responsible for production and sales has completed preparations, and the special drug is officially on the market.

These international conglomerates and pharmaceutical companies must have traced their information through publicly available company data, discovering that they held a 10% stake.

What does this 10% stake mean?

This means annual dividends of billions or even tens of billions.

This means they have a say in this effective drug.

This signifies a trendsetter for the pharmaceutical industry for the next few decades.

This is a huge cake.

It's big enough that international conglomerates would set aside their pride and personally call to "discuss business."

Luo Fei figured it out.

He picked up his phone again.

Another call came in from an unknown number.

He answered the call.

"Feed?"

"Hello Mr. Luo Fei, I am..."

"No need to say anything more," Luo Fei interrupted them. "I know what you want."

There was a pause on the other end of the phone.

"Mr. Luo Fei..."

"Bai Ruizhe's shares, right?"

There was a moment of silence on the other end of the phone.

Then the voice became even more fervent.

"Mr. Luo Fei is indeed very perceptive. Yes, our company is very interested in the shares you hold. As long as you are willing to sell, we can discuss any terms."

"Name your price. After the share transfer, you can also serve as an advisor to our company, with an annual salary starting at tens of millions."

"If you are willing to collaborate on developing new products, we can provide even more resources and support..."

Luo Fei listened quietly, and then he spoke.

"I'm not interested."

hang up.

The next call came almost seamlessly.

"Mr. Luo Fei, we can offer 5 billion Chinese Yuan to acquire 5% of your shares..."

"Mr. Luo Fei, we can provide funding in the tens of billions to help you establish your own pharmaceutical company..."

"Mr. Luo Fei, if you are willing to cooperate with us, we can help you immigrate to the United States, providing the best living conditions and security, and allowing your next generation to enjoy the world's top educational resources..."

The phone kept ringing.

The asking price is getting higher and higher, and the conditions are getting more and more outrageous.

Luo Fei finally lost his patience.

He opened his phone settings and enabled the option to reject calls from unknown numbers.

Then he tossed his phone aside, leaned against the headboard, and closed his eyes.

The world is finally peaceful.

Meanwhile, in Shanghai at this time...

The top floor of a high-end office building.

Yamamoto Ichiro sat in his office, holding the phone that Luo Fei had just hung up, his face somewhat gloomy.

Suddenly, a shrill ringtone sounded. The caller was his immediate superior—Masao Yamamoto, the president of Yamamoto Corporation headquarters.

"Baka!" The moment the call connected, Masao Yamamoto's voice came through the phone, filled with suppressed anger. "You idiot, you can't even handle something this simple?"

Ichiro Yamamoto's forehead was covered in sweat.

"President, that person didn't even listen to me finish speaking before hanging up. When I called back, I couldn't get through."

Masao Yamamoto remained silent for a few seconds.

Do you know what that drug means?

Yamamoto Ichiro dared not speak.

"That medicine can completely cure leukemia."

"Hundreds of thousands of new leukemia patients are diagnosed across the entire planet every year, with millions of current patients."

"Everyone needs it, and everyone has to spend money on it."

"This is a market worth hundreds of billions."

"And that person owns 10 percent of the shares."

Masao Yamamoto's voice grew colder and colder.

"Do you understand how much profit that 10% represents each year?"

Sweat streamed down Yamamoto Ichiro's face.

"Hi! I understand!"

"You understand?" Masao Yamamoto sneered. "Then tell me, why have others already taken action, and what have you done?"

Yamamoto Ichiro lowered his head.

"It's because my subordinates are incompetent."

Masao Yamamoto took a deep breath.

I'll give you one more chance.

"We must get those shares from that person at all costs. I don't care what methods you use, I just want to see results."

Yamamoto Ichiro gritted his teeth.

"Hi!"

At the same time.

Another building in Shanghai.

Inside the Locke family representative office.

Emily put down the phone and looked at the projection screen in front of her.

The projection showed an elderly man with gray hair—David Locke, the current patriarch of the Locke family.

"He refused?" David asked.

Emily nodded.

"Yes, sir. After listening to my self-introduction, he only said 'not interested' and then hung up."

David remained silent for a few seconds.

Then he laughed, a laugh that was quite meaningful.

"interesting."

"This young man is more interesting than I imagined."

Emily was puzzled.

"Sir, he refused us. Aren't you angry?"

David shook his head.

"Angry? Why are you angry?"

"An ordinary person, faced with an invitation from the Locke family, was able to refuse without hesitation."

What does this mean?

Emily thought for a moment.

"Does this mean he doesn't care about money?"

David nodded.

"It's not just that he doesn't care about money, he also doesn't care about our reputation, our power, or anything else we can give him."

"This kind of person is either a fool, or he has enough confidence."

Do you think he's an idiot?

Emily shook her head.

"It doesn't look like it."

“Yes,” David said. “He isn’t, so he has a reason to be confident. But where does his confidence come from?”

Emily paused for a moment.

"You mean the government of the Dragon Kingdom?"

David nodded.

"China owns 90% of that drug."

"The Chinese government must be backing this up."

"The 10% that person holds is less a share and more a reward from the state to a meritorious official."

"How could the Dragon Kingdom government so easily give away such a reward?"

Emily suddenly realized.

"Then we should..."

David waved his hand.

"No rush, let's see what others do first. This pie is too big, and too many people want a slice. Let them try and get a piece of the pie first."

He smiled.

"We have plenty of patience. It's not too late to act once we've assessed the situation."

GlaxoSmithKline headquarters, England.

CEO Emma Watson sat in the conference room, facing a group of executives.

"Gentlemen, news has come from the Dragon Kingdom that the target has clearly rejected our contact."

Silence fell over the meeting room.

An executive spoke up.

"Should we raise the price a bit more?"

Emma shook her head.

"It's not about money; that person doesn't care about money at all."

Another executive frowned.

"So what does he care about?"

Emma thought about it.

"Perhaps, there are things he cares about that we can't give him."

Silence fell over the meeting room once again.

a long time.

Emma spoke.

"Keep an eye on it."

"At the same time, we will activate the second plan and contact people in the Dragon Kingdom government."

The executives nodded in agreement.

Headquarters of Bayer Group, Germany.

Hans Müller stood in front of the large screen and reported the situation to senior management at headquarters.

"That person rejected us."

On the screen, an elderly man with white hair spoke.

"reason?"

Hans Müller shook his head helplessly: "I don't know. He didn't give us a chance to explain in detail. After hearing my self-introduction and purpose, he hung up the phone directly."

The old man remained silent for a few seconds, and the atmosphere in the office became somewhat oppressive.

Then, in a commanding tone, he said, "Continue trying to contact him, by any means necessary. At the same time, immediately launch a full investigation. I need all information about him, including his family, friends, lifestyle, social circle, and any weaknesses he might have. Remember, Hans, everyone has weaknesses. If we find his weaknesses, we'll find a breakthrough."

Hans Müller's spirits lifted, and he nodded quickly, "Yes, Chairman! I'll take care of it right away!"

Almost simultaneously, top executives from leading conglomerates and well-known pharmaceutical companies across multiple countries on Earth were engaged in heated discussions in their conference rooms, all revolving around the same name—Luo Fei.

A young Chinese man whom they had never met or even heard of before suddenly became the focus of global capital pursuit because of a miracle drug that could change the world.

And this moment.

The young man was lying in a villa in a small county town in China, with his eyes closed, listening to the chirping of insects outside the window.

It was very quiet and relaxing.

Luo Fei rolled over.

I remembered there was something I hadn't done yet.

The phone screen displayed dozens of blocked calls in the message notifications.

He ignored that and found Su Wanqing's number.

The call was made.